Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.47 |
| ▸ | GRN | P28799 | 2/20 | 0.46 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.46 |
| ▸ | MME | P08473 | 1/20 | 0.46 |
| ▸ | LAP3 | P28838 | 3/20 | 0.45 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.43 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL468911 | 1.00 | ALDH1A1 (0.67) | ALDH1A1MAPTMEN1LMNAKMT2A | |
| SCHEMBL14436768 | 0.84 | ALDH1A1 (0.55) | ALDH1A1MAPTMEN1LMNAKMT2A | |
| SCHEMBL15757059 | 0.83 | ALDH1A1 (0.53) | ALDH1A1MAPTMEN1LMNAKMT2A | |
| SCHEMBL19545981 | 0.83 | MMP1 (0.53) | ALDH1A1MAPT | |
| SCHEMBL8017457 | 0.83 | ALDH1A1 (0.53) | ALDH1A1MAPTMEN1LMNAKMT2A | |
| SCHEMBL19967700 | 0.83 | ALDH1A1 (0.53) | ALDH1A1MAPTMEN1LMNAKMT2A | |
| SCHEMBL26079410 | 0.81 | ALDH1A1 (0.60) | ALDH1A1MAPTMEN1LMNAKMT2A | |
| SCHEMBL865121 | 0.81 | TGFBR1 (0.52) | ALDH1A1MAPTFOLH1MMENAALAD2 | |
| SCHEMBL865120 | 0.81 | TGFBR1 (0.52) | ALDH1A1MAPTFOLH1MMENAALAD2 | |
| SCHEMBL29590916 | 0.81 | ALDH1A1 (0.51) | ALDH1A1MAPTMEN1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2311452-B2 | Topical composition comprising n-acetyl glucosamine | YU RUEY J (US) | 2020-12-30 | — | — | EP | disclosed |
| EP-2311452-B9 | Topical composition comprising n-acetyl glucosamine | YU RUEY J (US) | 2014-12-24 | — | — | EP | disclosed |
| US-RE44302-E1 | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use | YU RUEY J (US) | 2013-06-18 | — | — | US | disclosed |
| US-RE44017-E1 | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use | YU RUEY J (US) | 2013-02-19 | — | — | US | disclosed |
| US-RE42902-E1 | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use | TRISTRATA, INC. (US) | 2011-11-08 | — | — | US | disclosed |
| EP-2311452-A1 | Topical composition comprising n-acetyl glucosamine | Yu, Ruey J. (US) | 2011-04-20 | — | — | EP | disclosed |
| US-RE41339-E1 | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use | TRISTRATA, INC. (US) | 2010-05-18 | — | — | US | disclosed |
| US-RE41278-E1 | N-acetyl aldosamines and related N-acetyl compounds, and their topical use | TRISTRATA, INC. | 2010-04-27 | — | — | US | disclosed |
| EP-2080504-A2 | Topical composition comprising n-acetylaldosamines or n-acetylamino acids | Yu, Ruey J. (US) | 2009-07-22 | — | — | EP | disclosed |
| EP-1639994-A2 | Topical composition comprising N-acetylaldosamines or N-acetylamino acids | Yu, Ruey J., Dr. (US) | 2006-03-29 | — | — | EP | disclosed |
| EP-1570840-A2 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | Yu, Ruey J., Dr. (US) | 2005-09-07 | — | — | EP | disclosed |
| US-6524593-B1 | Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails | TRISTRATA, INC. | 2003-02-25 | — | — | US | disclosed |
| EP-1143925-A1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | Yu, Ruey J., Dr. (US) | 2001-10-17 | — | — | EP | disclosed |
| US-6159485-A | COSMETICS; SKIN DISORDERS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-12-12 | — | — | US | disclosed |
| WO-2000040217-A1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-07-13 | — | — | WO | disclosed |
| EP-0050196-B1 | PROCESS FOR THE PREPARATION OF PEPTIDES | Degussa Aktiengesellschaft (DE) | 1983-11-23 | — | — | EP | disclosed |
| US-4374062-A | ASSYMETRICAL HYDROGENATION OF DEHYDROPEPTIDES USING A PHODIUM COMPLEX CATALYST | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1983-02-15 | — | — | US | disclosed |
| EP-0050196-A1 | Process for the preparation of peptides | Degussa Aktiengesellschaft (DE) | 1982-04-28 | — | — | EP | disclosed |